Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk -Benefit Decision Making in Metoidioplasty and Phalloplasty Surgeries (MaPS)

NCT06565663 is registered in ClinicalTrials.gov with Dartmouth-Hitchcock Medical Center as lead sponsor.

NCT NCT06565663
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06565663 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk -Benefit Decision Making in Metoidioplasty and Phalloplasty Surgeries (MaPS)
Lead sponsor
Dartmouth-Hitchcock Medical Center
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
October 23, 2024
Completion date
March 6, 2028
Enrollment
140 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

gender dysphoria, gender dysphoria, adult, gender incongruence, phalloplasty, transgender persons, transgenderism, transsexualism